Skip to content
★ Sign in to follow
AL

Anders Lilja

HOOKIPA Pharma Inc.
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€132k

Latest filing published 27 Jan 2020 for HOOKIPA Pharma Inc., €367.

Filing timeline

BuySale
Anders Lilja

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

Anders Lilja: trading record in brief

Anders Lilja is a declared insider of HOOKIPA Pharma Inc., with filings sourced from SEC (Form 4). The record holds 4 filings, all for trades on 23 January 2020.

The open-market record consists of 2 sales worth €132k, with no purchase. Besides market trades, the filings include 2 option exercises.

Most recently, on 27 January 2020, the filings show an option exercise worth €367 in HOOKIPA Pharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Anders Lilja

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◇
    Sr. VP, Technical DevelopmentExecutivesHOOKIPA Pharma Inc.
    408 USD11SEC
    4,075 shares@ US$0.100.3% of flowCommon StockSEC:0001104659-20-007181:0
  • ▼
    Sr. VP, Technical DevelopmentExecutivesHOOKIPA Pharma Inc.
    49,601 USD26SEC
    4,075 shares@ US$12.172133.6% of flowCommon StockSEC:0001104659-20-007181:1
  • ◇
    Sr. VP, Technical DevelopmentExecutivesHOOKIPA Pharma Inc.
    757 USD11SEC
    7,568 shares@ US$0.100.5% of flowCommon StockSEC:0001104659-20-007181:2
  • ▼
    Sr. VP, Technical DevelopmentExecutivesHOOKIPA Pharma Inc.
    96,932 USD30SEC
    7,568 shares@ US$12.808165.6% of flowCommon StockSEC:0001104659-20-007181:3

4 of 4 declarations